Patents by Inventor Frederik PAUWELS

Frederik PAUWELS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E
    Publication number: 20230310481
    Abstract: The present disclosure is directed toward bi- and monocyclic nucleoside analogs, and compositions comprising these compounds for use in the treatment of hepatitis E infections.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 5, 2023
    Inventors: Tim Hugo Maria JONCKERS, Frederik PAUWELS, Yannick DEBING
  • SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF HEPATITIS E
    Publication number: 20230201236
    Abstract: The present disclosure is directed toward spirocyclic nucleoside analogs, compositions comprising these compounds, and their use for treating hepatitis E infections.
    Type: Application
    Filed: April 13, 2021
    Publication date: June 29, 2023
    Inventors: Tim Hugo Maria JONCKERS, Frederik PAUWELS, Yannick DEBING
  • ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E
    Publication number: 20230201239
    Abstract: The present disclosure is directed toward alkynyl nucleoside analogs, compositions comprising these compounds, and their use for treating hepatitis E infections.
    Type: Application
    Filed: April 13, 2021
    Publication date: June 29, 2023
    Inventors: Tim Hugo Maria JONCKERS, Frederik PAUWELS, Yannick DEBING
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND CAPSID ASSEMBLY MODULATORS BEING SULFONAMIDE DERIVATIVES
    Publication number: 20220305116
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and a capsid assembly modulator are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 29, 2022
    Inventors: Helen HORTON, Jan BERKE, Frederik PAUWELS
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND DIHYDROPYRIMIDINE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS
    Publication number: 20220249647
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and capsid assembly modulators are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: August 11, 2022
    Inventors: Helen HORTON, Jan Martin BERKE, Frederik PAUWELS
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND DIHYDROPYRIMIDINE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS
    Publication number: 20220233526
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and capsid assembly modulators are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: July 28, 2022
    Inventors: Helen HORTON, Jan Martin BERKE, Frederik PAUWELS